COVID

Q: How many drugs are in development for COVID?

BioSniper tracks 185 drugs in development for COVID across 72 companies.

Q: How many clinical trials target COVID?

There are 1 clinical trial targeting COVID tracked by BioSniper.

Infectious Disease

185 drugs in development·72 companies·1 clinical trial

Drug Pipeline by Phase

Approved(14)

Drug	Company
1copy tm covid-19 qpcr multi kit	GLOBAL WHOLEHEALTH PARTNERS CORP (GWHP)
chemical entity	Decoy Therapeutics Inc. (DCOY)
cleancap-enabled mrna programs	MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
covid-19 antibody tests	Ortho Clinical Diagnostics Holdings plc (OCDX)
COVID-19 diagnostic tests	BIOMERICA INC (BMRA)
kostaive	Arcturus Therapeutics Holdings Inc. (ARCT)
KOSTAIVE (ARCT-154)	Arcturus Therapeutics Holdings Inc. (ARCT)
nuvaxovid	NOVAVAX INC (NVAX)
Olumiant	ELI LILLY & Co (LLY)
Olumiant®	ELI LILLY & Co (LLY)
paxlovid	PFIZER INC (PFE)
pemgarda	Invivyd, Inc. (IVVD)
Sotrovimab	Xencor Inc (XNCR)
tofidence	BIOGEN INC. (BIIB)

Phase 3(30)

Drug	Company
abx464	Abivax SA (ABVX)
ABX464	Abivax SA (ABVX)
ARCT-2301 (bivalent KOSTAIVE)	Arcturus Therapeutics Holdings Inc. (ARCT)
ARCT-2303 (Monovalent XBB1.5)	Arcturus Therapeutics Holdings Inc. (ARCT)
bezisterim (NE3107)	BIOVIE INC. (BIVI)
BNT162b2	ENANTA PHARMACEUTICALS INC (ENTA)
BNT162b2 Vaccine	BioNTech SE (BNTX)
Cannabidiol, pharmaceutically produced with < 5 ppm THC	Cardiol Therapeutics Inc. (CRDL)
cic	NOVAVAX INC (NVAX)
cic vaccine co-formulated tniv2	NOVAVAX INC (NVAX)
Lagevrio	Merck & Co., Inc. (MRK)
Licensed Influenza Vaccine	Moderna, Inc. (MRNA)
Molnupiravir	Merck & Co., Inc. (MRK)
Niclosamide	UNITED THERAPEUTICS Corp (UTHR)
novavax covid-19 vaccine	NOVAVAX INC (NVAX)
nvx-cov2373	NOVAVAX INC (NVAX)
nvx-cov2705	Sanofi (SNY)
NVX-CoV2705	Sanofi (SNY)
pacritinib	CTI BIOPHARMA CORP (CTIC)
prototype/xbb.1.5 bivalent vaccine	NOVAVAX INC (NVAX)
remestemcel-l	Mesoblast Limited (MESO)
riv	Sanofi (SNYNF)
sars-cov-2 adjuvanted recombinant protein vaccine	Sanofi (SNY)
sars-cov-2 rs antigen/matrix-m adjuvant	NOVAVAX INC (NVAX)
SARS-CoV-2 Vaccine	Moderna, Inc. (MRNA)
tniv vaccine	NOVAVAX INC (NVAX)
Tocilizumab	Crinetics Pharmaceuticals, Inc. (CRNX)
vyd2311	Invivyd, Inc. (IVVD)
vyd2311-md	Invivyd, Inc. (IVVD)
vyd2311-sd	Invivyd, Inc. (IVVD)

Phase 2(51)

Drug	Company
Anktiva	ImmunityBio, Inc. (IBRX)
aprepitant injectable emulsion	HERON THERAPEUTICS, INC. /DE/ (HRTX)
ARCT-021 single dose priming	Arcturus Therapeutics Holdings Inc. (ARCT)
ARCT-021 two higher dose priming	Arcturus Therapeutics Holdings Inc. (ARCT)
ARCT-021 two lower dose priming	Arcturus Therapeutics Holdings Inc. (ARCT)
ARCT-154 Self-Amplifying RNA SARS-CoV-2 Vaccine	Arcturus Therapeutics Holdings Inc. (ARCT)
ARCT-810	Arcturus Therapeutics Holdings Inc. (ARCT)
Astra Zeneca COVID-19 vaccine	Arcturus Therapeutics Holdings Inc. (ARCT)
Atilotrelvir/ritonavir	ENANTA PHARMACEUTICALS INC (ENTA)
BNT162b2	BioNTech SE (BNTX)
Ciclesonide	UNITED THERAPEUTICS Corp (UTHR)
coral	Gritstone bio, Inc. (GRTS)
covid-19 vaccine	GeoVax Labs, Inc. (GOVX)
EDP-235	ENANTA PHARMACEUTICALS INC (ENTA)
Ensitrelvir	ENANTA PHARMACEUTICALS INC (ENTA)
Favipiravir	ENANTA PHARMACEUTICALS INC (ENTA)
Fluoxetine	ENANTA PHARMACEUTICALS INC (ENTA)
geo-cm04s1	GeoVax Labs, Inc. (GOVX)
HB-adMSC	UNITED THERAPEUTICS Corp (UTHR)
Hydroxychloroquine	ENANTA PHARMACEUTICALS INC (ENTA)
imc-2	Dogwood Therapeutics, Inc. (DWTX)
Ivabradine + Coordinated Care	Valneva SE (VALN)
Ivabradine + Usual Care	Valneva SE (VALN)
Ivermectin	ENANTA PHARMACEUTICALS INC (ENTA)
IVIG + Coordinated Care	Valneva SE (VALN)
IVIG + Usual Care	Valneva SE (VALN)
ivx-411	Icosavax, Inc. (ICVX)
Janssen Ad26COVS1	ENANTA PHARMACEUTICALS INC (ENTA)
Molnupiravir	ENANTA PHARMACEUTICALS INC (ENTA)
Molnupiravir and nirmatrelvir/ritonavir	ENANTA PHARMACEUTICALS INC (ENTA)
Monoclonal antibodies	ENANTA PHARMACEUTICALS INC (ENTA)
NANT Cancer Vaccine	ImmunityBio, Inc. (IBRX)
NE3107	BIOVIE INC. (BIVI)
Nirmatrelvir/ritonavir	ENANTA PHARMACEUTICALS INC (ENTA)
Nitazoxanide	ENANTA PHARMACEUTICALS INC (ENTA)
nv-387	NANOVIRICIDES, INC. (NNVC)
ovydso	Sorrento Therapeutics, Inc. (SRNE)
paxlovid	TRAWS PHARMA, INC. (ONTX)
Paxlovid 10 days	Valneva SE (VALN)
Paxlovid 5 days	Valneva SE (VALN)
pomotrelvir	PARDES BIOSCIENCES, INC. (PRDS)
ProLectin-M	BIOXYTRAN, INC (BIXT)
Randomized booster	Arcturus Therapeutics Holdings Inc. (ARCT)
ratutrelvir	TRAWS PHARMA, INC. (ONTX)
ratutrelvir non-randomised	TRAWS PHARMA, INC. (ONTX)
Remdesivir	ENANTA PHARMACEUTICALS INC (ENTA)
Sotrovimab	UNITED THERAPEUTICS Corp (UTHR)
Sotrovimab	ENANTA PHARMACEUTICALS INC (ENTA)
synthetic mva-based sars-cov-2 vaccine geo-cm04s1	GeoVax Labs, Inc. (GOVX)
Veklury	Valneva SE (VALN)
vxa-cov2-1.1-s	Vaxart, Inc. (VXRT)

Phase 1(21)

Drug	Company
AAHI-SC2 Vaccine	ImmunityBio, Inc. (IBRX)
AAHI-SC3 Vaccine	ImmunityBio, Inc. (IBRX)
ALG-097558	Aligos Therapeutics, Inc. (ALGS)
Aluminum Hydroxide Suspension	Cidara Therapeutics, Inc. (CDTX)
ARCT-021	Arcturus Therapeutics Holdings Inc. (ARCT)
ARCT-154	Arcturus Therapeutics Holdings Inc. (ARCT)
ARCT-165	Arcturus Therapeutics Holdings Inc. (ARCT)
Boost-2867	Cidara Therapeutics, Inc. (CDTX)
covid-higiv	Emergent BioSolutions Inc. (EBS)
COVID-HIGIV	UNITED THERAPEUTICS Corp (UTHR)
CpG 7909	Cidara Therapeutics, Inc. (CDTX)
EUA or approved vaccine	ImmunityBio, Inc. (IBRX)
glb-cov2-043	GreenLight Biosciences Holdings, PBC (GRNA)
mdx2301	OPKO HEALTH, INC. (OPK)
ocu500	Ocugen, Inc. (OCGN)
ocu520	Ocugen, Inc. (OCGN)
oravax oral vaccine	ORAMED PHARMACEUTICALS INC. (ORMP)
PepGNP-COVID19	Merus N.V. (MRUS)
StealthX™ exosome protein-based vaccine (multivalent design)	CAPRICOR THERAPEUTICS, INC. (CAPR)
tvgn 489	Tevogen Bio Holdings Inc. (TVGN)
vbi-2901a	VBI VACCINES INC/BC (VBIV)

Preclinical(24)

Drug	Company
Anti-viral SARS-CoV-2 Mpro inhibitor candidate	Anixa Biosciences Inc (ANIX)
autovac	Orgenesis Inc. (ORGS)
civax	SOLIGENIX, INC. (SNGX)
co-dx pcr flu a/b	Co-Diagnostics Inc. (CODX)
combination covid-19	Lucira Health, Inc. (LHDX)
covid-19 product candidate	Raphael Pharmaceutical Inc. (RAPH)
covid-19 vaccine	MYMETICS CORP (MYMX)
covid-19 vaccine	Nascent Biotech Inc. (NBIO)
covid-19 vaccine	GreenLight Biosciences Holdings, PBC (GRNA)
ii-key-sars-cov-2 coronavirus peptide vaccine	GENEREX BIOTECHNOLOGY CORP (GNBT)
kb109	Kaleido Biosciences, Inc. (KLDO)
lwel-2103	Luckwel Pharmaceuticals Inc. (LKYM)
man-19	Q BioMed Inc. (QBIO)
mrt5500	Translate Bio, Inc. (TBIO)
nhāler	Rapid Therapeutic Science Laboratories, Inc. (RTSL)
nv-cov-2	NANOVIRICIDES, INC. (NNVC)
nv-cov-2-r	NANOVIRICIDES, INC. (NNVC)
ProLectin-A	BIOXYTRAN, INC (BIXT)
ProLectin-F	BIOXYTRAN, INC (BIXT)
ProLectin-I	BIOXYTRAN, INC (BIXT)
sars-cov-2 ii-key peptide vaccine	NUGENEREX IMMUNO-ONCOLOGY, INC. (NGIO)
sars-cov-2 vaccine	GENETHERA INC (GTHR)
sti-1557	Sorrento Therapeutics, Inc. (SRNE)
tri	Decoy Therapeutics Inc. (DCOY)

Unknown(9)

Drug	Company
ana001	MetaVia Inc. (MTVA)
Anti-viral drug candidates for COVID-19	Anixa Biosciences Inc (ANIX)
AR-701	Aridis Pharmaceuticals, Inc. (ARDS)
Bivalent ARCT-2301	Arcturus Therapeutics Holdings Inc. (ARCT)
COVID-19 antigen tests	BIOMERICA INC (BMRA)
diphenhydramine	Mesoblast Limited (MESO)
High-end wine products	China Foods Holdings Ltd. (CFOO)
ProLectin-Rx	BIOXYTRAN, INC (BIXT)
SARS-CoV-2 neutralizing antibody tests	AXIM BIOTECHNOLOGIES, INC. (AXIM)

Phase 1/Phase 2(18)

Drug	Company
cov2 pres dtm without adjuvant	Sanofi (SNY)
cov2 pres dtm-af03	Sanofi (SNY)
cov2 pres dtm-as03	Sanofi (SNY)
iiv-hd	Sanofi (SNYNF)
iiv-hd	Sanofi (SNY)
iiv-hd + rc19	Sanofi (SNY)
iiv-hd + rc19	Sanofi (SNYNF)
rc19	Sanofi (SNYNF)
rc19	Sanofi (SNY)
riv	Sanofi (SNY)
riv + rc19	Sanofi (SNYNF)
riv + rc19	Sanofi (SNY)
sars-cov-2 mrna vaccine formulation 1	Sanofi (SNY)
sars-cov-2 mrna vaccine formulation 2	Sanofi (SNY)
sars-cov-2 mrna vaccine formulation 3	Sanofi (SNY)
vbi-2901	VBI VACCINES INC/BC (VBIV)
vbi-2902	VBI VACCINES INC/BC (VBIV)
vbi-2905	VBI VACCINES INC/BC (VBIV)

Phase 2/Phase 3(8)

Drug	Company
adintrevimab	Invivyd, Inc. (IVVD)
ensovibep	Novartis AG (NVS)
inb03	Inmune Bio, Inc. (INMB)
opaganib	RedHill Biopharma Ltd. (RDHL)
sars-cov-2 recombinant protein vaccine phase 2 formulation 1	Sanofi (SNY)
sars-cov-2 recombinant protein vaccine phase 2 formulation 2	Sanofi (SNY)
sars-cov-2 recombinant protein vaccine phase 2 formulation 3	Sanofi (SNY)
sars-cov-2 rs/matrix-m1 adjuvant	NOVAVAX INC (NVAX)

Phase 4(10)

Drug	Company
Intervention group	Valneva SE (VALN)
mRNA-1083	Moderna, Inc. (MRNA)
mRNA-1273.222	Moderna, Inc. (MRNA)
mRNA-1273.815	Moderna, Inc. (MRNA)
mRNA-1283.222	Moderna, Inc. (MRNA)
mRNA-1283.251 Variant-containing Formulation	Moderna, Inc. (MRNA)
mRNA-1283.815	Moderna, Inc. (MRNA)
nvx-cov2705	NOVAVAX INC (NVAX)
pfizer mrna covid-19 vaccine	NOVAVAX INC (NVAX)
protein subunit	NOVAVAX INC (NVAX)

Compare drugs

1copy tm covid-19 qpcr multi kit vs chemical entity 1copy tm covid-19 qpcr multi kit vs cleancap-enabled mrna programs 1copy tm covid-19 qpcr multi kit vs covid-19 antibody tests

Frequently asked questions

How many drugs are in development for COVID?

BioSniper tracks 185 drugs in development for COVID across 72 companies.

How many clinical trials target COVID?

There are 1 clinical trial targeting COVID tracked by BioSniper.

Deep-dive into COVID

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis